Belarus has registered a semaglutide-based drug "Semavik," intended for the treatment of type 2 diabetes.
It has become the first official analog of the original Danish "Ozempic" in the country and is already available to patients, writes "Meditsinsky Vestnik" (Medical Herald).
The original Danish medical drug gained worldwide fame back in 2022 thanks to its "side" effect — it helps to quickly reduce excess weight, recalls Onliner.by.
Previously, in Belarusian pharmacies, it could only be purchased with one-time permits from the Ministry of Health: the unregistered drug was imported into the country on a case-by-case basis. Because of this, the medicine was not always available in stock and in the required quantity.
Now, the Ministry of Health has officially certified an alternative. The manufacturer of the first analog registered in the country is the Russian pharmaceutical company "Geropharm."
The drug is strictly prescription-only. The price of the injection solution in pharmacies ranges between 261–280 rubles.
Now reading
An old stone building near the town hall in Mogilev was being prepared for the city museum. Now it's being turned into an office for the Russian embassy, headed by a former 'LPR' minister 1414
An old stone building near the town hall in Mogilev was being prepared for the city museum. Now it's being turned into an office for the Russian embassy, headed by a former 'LPR' minister 14
Organizers of Belarusian TEDx in Warsaw Still Haven't Received Money for Sold Tickets — Belarusian's Company Has Been Delaying Payments for 4 Months 33
Comments
Па-другое, яны купляюць кітайскі семаглутыд і разліваюць яго ў закупленыя шпрыцы — вось і ўся іх вытворчасць. Пры гэтым кошты як у Расіі, так і ў Беларусі выглядаюць трохі неадэкватнымі затрачаным намаганням і сродкам.
Па-трэцяе, «Семавік», як і «Аземпік», маральна састарэлі. Зараз актуальны прэпарат «Седжара», які таксама выпускаецца «Герафармам». Ён з’яўляецца аналагам амерыканскага «Мунджара», які ўжо вядомы ў Беларусі па ўжыванні адным палітычным дзеячам.
Тым не менш, гэта навіна добрая: прэпарат рабочы і запатрабаваны ва ўсім свеце.